Blood tests for Alzheimer's disease
Plasma p-tau and other blood biomarkers for Alzheimer's pathology.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 14, 16, 30, 79, 88.
All papers from the last 12 months
949 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Analytical validation and clinical performance of a chemiluminescence immunoassay panel for plasma biomarkers in Alzheimer's disease: a preliminary studyClin Chim Acta2027 Feb 15PMID 42668129
- An accessible digital single-molecule sensing platform for plasma P-tau217 quantification in Alzheimer's disease screeningClin Chim Acta2027 Feb 15PMID 42556454
- Simultaneous and ultrasensitive detection of Alzheimer's disease blood biomarkers using magnetic SERS-encoded tags-based LFIA assayTalanta2027 Feb 1PMID 42508312
- Blautia coccoides-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signalingGut Microbes2026 Dec 31PMID 41459734
- Prefrontal hemodynamic alterations during resting state and stroop interference in cognitively healthy older adults with high plasma pTau-217 levelsNeuroimage Rep2026 DecPMID 42787480
- Attentionally directed oculomotor training produces disease-stage-dependent effects on plasma tau, cognition, and oculomotor signatures in patients with mild cognitive impairmentGeroscience2026 DecPMID 42587262
- Genetic architecture of Alzheimer's disease-related plasma biomarkersNeurobiol Aging2026 DecPMID 42566983
- Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer's diseaseDialogues Clin Neurosci2026 DecPMID 42035365
- A proximity-allosteric Adapter unlocks Cas12a exponential amplification for versatile homogeneous assayAnal Chim Acta2026 Nov 15PMID 42838679
- Nanozyme-SERS cascade immunoassay: From in-situ generation to signal enhancement of diffusible reporters in hotspots of Ag-rich nanoshell monolayersBiosens Bioelectron2026 Nov 15PMID 42567126
More neurology trends
All specialties →Focused ultrasound for tremor
MR-guided focused ultrasound for essential tremor and Parkinson's disease.
Key point: MRgFUS thalamotomy is safe, effective, and durable for refractory essential tremor; it appears safe and effective for Parkinson disease tremor, with uncertain durability.
Auricular vagus nerve stimulation
Studies of transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique.
CGRP-targeted migraine treatment
Gepants and anti-CGRP antibodies for migraine.
Tenecteplase in stroke
Tenecteplase as the thrombolytic for acute ischaemic stroke.
Key point: Intravenous tenecteplase before thrombectomy showed benefit in ASPECTS <8, but no functional improvement and possible safety concerns in ASPECTS 8-10.
Post-stroke dysphagia
Studies of swallowing disorders after stroke and their treatment, including neuromodulation.
Anti-amyloid antibodies
Lecanemab, donanemab and related antibodies for early Alzheimer's disease.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"p-tau217"[tiab] OR ptau217[tiab] OR "p-tau181"[tiab] OR "plasma phosphorylated tau"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.